- Project ID SAFIR-Med
- Project duration 2020-12-01 > 2022-11-30
- EU Contr. EUR 2.038.609,01
- Status Ongoing
The SAFIR-Med project’s vision is to achieve safe, sustainable, socially accepted and socially beneficial urban air mobility.
SAFIR-Med represents all value chain actors and stakeholder as either project partner (ATC, USPs, operators, UAS manufacturers, cities) or formal associate partner (major customers, technology and service providers) at a representative international level.
Five unmanned UAV platforms (passenger eVTOL, hydrogen fuel cell VTOL, battery tiltwing VTOL, AED medical drone, X8 medical transport) will be combined with manned aviation in real life exercises validating technology in real urban environment.
Technologies of all partners will be leveraged to make use of the maximum number of U-space services towards the highest possible operational safety level, including advanced detect and avoid U-space service.
The demonstrations will take place in the cities of Antwerp (BE), Aachen (DE) and Heerlen (NL), leveraging the MAHHL trans-border region, following a full de-risking exercise at the DronePort BVLOS test-facility in Sint-Truiden, Belgium.
The demonstration results will be further virtually enhanced through large-scale simulations in order to test the maximum airspace capacity of the CONOPS. The project results will then further be validated and made representable for the whole of the EU, by simulating demonstrations in two additional locations in Europe, namely Athens, Greece (South EU) and Prague, Czech Republic (East EU).
Lessons learnt will be documented in a performance assessment and recommendations report, providing refinements to the current U-space architecture principles and creating measurable indicators for UAM which will enable Smart Cities to include UAM in their transport roadmaps, support standardisation and thereby safety.
Finally, SAFIR-Med will have made an important contribution to the EU healthcare system, by ensuring that future generations will continue to democratically have access to the best cure and care.
SAFIR-Med project partners
- Helicus (Project coordinator and medical flight operator)
- Future Needs Management Consulting (Urban Air Mobility indicators for Smart Cities, Dissemination & Communication, Business Sustainability, Ethics & Data Protection)
- Skeyes (Air Traffic Control / ATC)
- Unifly (Unmanned Traffic Management software)
- AgentFly Technologies (Flight simulation and aerospace digital twin)
- Hellenic U-Space Institute (U-space services simulation)
- SkeyDrone (U-Space Service Provider / USSP)
- Droniq (U-Space Service Provider / USSP)
- NSX (Software platform integrator, following Normalised Systems Theory)
- INVOLI (Real time air traffic awareness)
- RWTH Aachen University, Institute of Flight System Dynamics (Demonstration Coordination and flight-permit in MAHHL-Region)
- flyXDrive (Tiltwing VTOL manufacturer)
- TUDelft, MAVlab (AED Medical drone and Detect-And-Avoid)
- HyFly (Hydrogen fuel cell VTOL)
- SABCA (X8 medical transport drone)
- EHang (Passenger eVTOL)
- City of Aachen (representing the MAHHL-Urban Air Mobility Initiative)
SAFIR-Med advisory board
- EASA (European Aviation Safety Agency)
- The Red Cross
- Baloise Insurance
- Zuyderland (healthcare group)
- Droneport (BVLOS test centre for unmanned aviation)
- Proximus (Telecom Operator)
- City of Antwerp
- Port of Antwerp
The project has received recognition and funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 101017701 under the topic “SESAR-VLD2-03-2020: U-space capabilities and services to enable Urban Air Mobility”.
This project has received funding from the SESAR Joint Undertaking under the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017701